iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Cipla-led arm recalls six batches of Albuterol Sulfate Inhalation

7 Jul 2023 , 01:27 PM

Cipla Limited announced that Cipla USA Inc., its wholly-owned subsidiary, is recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) voluntarily. These batches were manufactured in November 2021 to the consumer level.

The company stated in its risk statement that failure to deliver the recommended dose to treat the respiratory symptoms of an acute asthma exacerbation, such as wheezing, shortness of breath, coughing, and bronchospasms, due to device defect, has a reasonable chance of being fatal.

There were no reported adverse events for Albuterol Sulphate Inhalation Aerosol 90 mcg before this recall, said the company.

The Company is conducting a recall in the United States in response to a market complaint for a single inhaler (Batch Number – IB20056), where leakage was observed through the inhaler valve. As a precaution, the above-mentioned six batches manufactured with the same lot of valves are being recalled.

Cipla has informed its distributors and customers via letter, and arranged for the return and replacement of all recalled products. Consumers/distributors/retailers who have product from these six recalled batches should stop using it, return it to the place of purchase, or discard it, said the company.

For feedback and suggestions, write to us at editorial@iifl.com

explored-media

Related Tags

  • Cipla
  • Cipla news
  • Cipla Stock
  • Cipla Updates
  • Pharma news
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.